The American Hospital Association, joined by five other medical associations, urged the Federal Trade Commission to abandon its unprecedented policy to enforce the Hart-Scott-Rodino Act against state-approved mergers and acquisitions, specifically with Louisiana Children’s Medical Center’s state-approved merger with HCA Healthcare.
“Never before has the Commission attempted to enforce HSR against a state-controlled merger or acquisition,” the groups wrote. “Nor has any court ever held that HSR applies to such transactions. This action disregards Supreme Court precedent holding that ‘state action or official action directed by a state’ is exempt from the federal antitrust laws. … The Louisiana attorney general had compelling reasons to approve this merger. It was designed to increase access to clinical services and high-quality health care in the New Orleans region and to create expanded hubs for specialty care, innovation and academic medicine.”
In addition to AHA, the letter was signed by America’s Essential Hospitals, the Association of American Medical Colleges, Children’s Hospital Association, Federation of American Hospitals, and Louisiana Hospital Association.
Related Posts
What Investors Expect Out of Healthcare in the Rest of 2022
There were only 12 announced hospital mergers in the first quarter.
May 6, 2022
CMS: ACOs Saved Medicare $1.6B Overall in 2021 as Big Changes on the Horizon
The Centers for Medicare & Medicaid Services (CMS) announced that 2021 was the fifth year in a row that ACOs generated overall savings for Medicare and met quality targets.
August 31, 2022
Massachusetts Hospital Sues Architect, Alleging Firm Cost it Medicare Certification
With a final price tag of the new hospital at $89 million, the damages sought in the lawsuit would equal roughly 9 percent of the total project cost.
July 6, 2023
Walgreens’ Virtual Care Launch Signals Retailers’ Healthcare Edge
“There are more telehealth suppliers competing for a small share of virtual care consumers, or limited demand, which suggests heightened competition,” said Sanjula Jain, PhD, senior vice president of market strategy and chief research officer at Trilliant Health.
October 23, 2023